| Literature DB >> 34680064 |
Mikuláš Černohlávek1,2, Martina Brandejsová1, Petr Štěpán1, Hana Vagnerová1, Martina Hermannová1, Kateřina Kopecká1, Jaromír Kulhánek1, David Nečas2, Martin Vrbka2, Vladimir Velebný1, Gloria Huerta-Angeles1.
Abstract
Hyaluronan (HA) is widely used for eye drops as lubricant to counteract dry eye disease. High and low molecular weight HA are currently used in ophthalmology. However, a large portion of the current literature on friction and lubrication addresses articular (joint) cartilage. Therefore, eye drops compositions based on HA and its derivatized forms are extensively characterized providing data on the tribological and mucoadhesive properties. The physiochemical properties are investigated in buffers used commonly in eye drops formulations. The tribological investigation reveals that amphiphilic HA-C12 decreases the friction coefficient. At the same time, the combination of trehalose/HA or HAC12 enhances up to eighty-fold the mucoadhesiveness. Thus, it is predicted a prolonged residence time on the surface of the eye. The incorporation of trehalose enhances the protection of human keratinocytes (HaCaT) cells, as demonstrated in an in-vitro cell-desiccation model. The presence of trehalose increases the friction coefficient. Medium molecular weight HA shows significantly lower friction coefficient than high molecular weight HA. This research represents a first, wide array of features of diverse HA forms for eye drops contributing to increase the knowledge of these preparations. The results here presented also provide valuable information for the design of highly performing HA-formulations addressing specific needs before preclinic.Entities:
Keywords: biotribology; eye drops; friction; hyaluronan; lubrication
Mesh:
Substances:
Year: 2021 PMID: 34680064 PMCID: PMC8533502 DOI: 10.3390/biom11101431
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1(A) The activation of dodecanoic acid mediated by benzoyl chloride. (B) The esterification of medium molecular weight HA carried out in water/THF.
Figure 21H NMR spectrum of (A) Native HA (300 kDa) and esterified HA0-C12 measured in (B) D2O and (C) NaOD.
Sodium dodecanoyl hyaluronan (HA-C12) studied in this work.
| Entry a | Sample b | DSGC | Mw (kDa) d | Dry Matter | ash | T% f | τ g |
|---|---|---|---|---|---|---|---|
| 1 | HA0-C12 | 9.33 ± 032 | 199.4 ± 5.9 (1.6) | 86.83 ± 0.66 | 6.6 ± 0.09 | 99.2 ± 0.21 | 2.1 ± 0.4 |
| 2 | HA1-C12 | 8.73 ± 0.12 | 239.3 ± 2.9 (1.4) | 88.10 ± 0.16 | 7.4 ± 0.33 | 98.8 ± 0.30 | 2.8 ± 0.5 |
| 3 | HA2-C12 | 9.03 ± 0.10 | 311.2 ± 5.2 (1.4) | 88.66 ± 1.5 | 7.8 ± 0.66 | 98.9 ± 0.44 | 3.8 ± 0.2 |
| 4 | HA3-C12 | 7.73 ± 0.04 | 434.5 ± 1.9 (1.5) | 90.03 ± 1.3 | 4.9 ± 0.12 | 94.7 ± 1.4 | 5.8 ± 1.6 |
a All the reactions were optimized (1 eq. of fatty acid, 3 eq. of TEA, 0.05 eq. of DMAP). b Identification of the sample used in this work. c The degree of substitution determined by gas chromatography. d The Mw of HA-C12 and the polydispersity index (PDI = Mw/Mn) in brackets. e The dry matter and ash were determined by thermogravimetric analyses (TGA). f the transmittance at 660 nm at c = 1% (w/v). g τ is the turbidity.
Figure 3(A) Pin-on-plate configuration used in this work (B) The average friction coefficient of different silicone ball-hardness at normal force 1 N.
Figure 4Friction coefficient dependence on time for five commercial eye drops.
Figure 5(A) Development of friction coefficient for HA and HA2-C12 as a function of time (B) Average coefficient of friction of HA and HA2-C12 samples in saline buffer (P). (B) Comparison of coefficient of friction for native HA and HA2-C12 in saline (P) or trehalose (T) buffers, respectively.
Figure 6(A) Viscosity of eye drops determined as a function of shear rates (B) Mucoadhesive properties for eye drops with mucin III evaluated at shear rates 1–1000 s−1.
Viscosity values and mucoadhesive index for HA (0.3%) and HA-C12 (0.1–0.3%) determined in the presence of mucin III. The values are reported as an average (mean value ± SD, n = 3) at shear rate of 33.9 s−1.
| Entry | [%] | Sample | Medium | Viscosity (mPa·s) | Viscosity | Mucoadhesive Index (%) |
|---|---|---|---|---|---|---|
| 1 | - | Mucin III | HEPES | 4.97 | -- | -- |
| 2 | 0.3 | HA2 | HEPES | 14.68 ± 0.01 | 25.12 ± 3.18 | 27.83 |
| 3 | 0.3 | HA5 | HEPES | 17.88 ± 0.002 | 10.07 ± 0.003 | −49.8 |
| 4 | 0.3 | HA6 | HEPES | 119.93 ± 0.001 | 21.30 ± 0.001 | −72.6 |
| 5 | 0.3 | HA2 | trehalose | 8.15 ± 0.001 | 12.73 ± 0.002 | −2.95 |
| 6 | 0.3 | HA5 | trehalose | 17.64 ± 0.001 | 28.48 ± 0.004 | 25.78 |
| 7 | 0.3 | HA6 | trehalose | 49.33 ± 0.003 | 69.34 ± 0.004 | 26.69 |
| 8 | 0.10 | HA2-C12 | HEPES | 3.8 ± 0.04 | 7.69 ± 0.11 | −12.31 |
| 9 | 0.20 | HEPES | 7.38 ± 0.02 | 21.65 ± 0.11 | 75.30 | |
| 10 | 0.30 | HEPES | 12.91 ± 0.19 | 331.4 ± 37.09 | 1753.5 | |
| 11 | 0.30 | HA2-C12 | trehalose | 16.77 ± 0.003 | 494.63 ± 0.010 | 2175.2 |
| 12 | 0.10 | HA3-C12 | HEPES | 6.57 ± 0.75 | 11.67 ± 0.12 | 1.12 |
| 13 | 0.20 | HEPES | 13.53 ± 0.37 | 58.07 ± 1.06 | 213.89 | |
| 14 | 0.30 | HEPES | 26.53 ± 0.96 | 156.83 ± 3.94 | 397.87 | |
| 15 | 0.30 | HA3-C12 | trehalose | 68.87 ± 0.001 | 226.30 ± 0.002 | 254.14 |
Figure 7(A) The hydration-protection effect against desiccation after pre-treatment for HA (in HEPES or trehalose buffers) 0.3 wt.%. Results are mean ± SD, n = 3. (B) The hydration-protection effect against desiccation after pre-treatment for HA, HA2-C12 and OTC products. (C)The hydration-protection against desiccation after pre-treatment with selected OTC products. The results are an average (mean value ± SD, n = 6) Significant differences (p < 0.05) were compared to the control “dry cells” (D) Optical microscopic imagen of cell protection obtained for HA2-C12 (scale bar = 300 µm).